ReliaTect® and Post-Op Risk Prevention

This 3-part series has reviewed the financial impact of SSIs  and emerging trends in SSI prevention. It is well accepted that hospital-acquired infection (HAI) after surgery or insertion of a device increases morbidity, mortality, and costs of care for patients and hospitals. Emerging trends in SSI prevention include antimicrobial dressings, with the purpose of protecting…

Introducing ReliaTect Post-Op Dressing

Eloquest Healthcare recently introduced ReliaTect™ Post-Op Dressing featuring BeneHold™ CHG Adhesive Technology. ReliaTect is the post-op dressing that integrates the antimicrobial properties of chlorhexidine gluconate (CHG), the practicality of absorbency, and the convenience of transparency. THE ANTIMICROBIAL POST-OP DRESSING WITH ABSORB&SEE ReliaTect has convenience features for staff1: ABSORBS EXUDATE to protect against dehydration and facilitate…

Antimicrobial Dressings: The Silver Mystique

As mentioned in our last posting, SSIs are the most common and costly of all hospital-acquired infections in the US.1 If you happened to have missed it, read it here. Accordingly, efforts to reduce SSI rates have led to the development of post-op dressings with antimicrobial agents impregnated within the dressing. These dressing inhibit the…

SSIs and Post-Op Dressings: What’s Missing?

You might remember from our previous blogs that certain measures, like surgical site infections (SSIs) are penalized in multiple programs of the Affordable Care Act—in the Value-Based Purchasing Program as well as the Hospital-Acquired Conditions Reduction Program. View Blog #2 and Blog #3 here. SSIs are the most common and costly of all hospital-acquired infections…